NCT02575703View on ClinicalTrials.gov

A Study of [¹⁴C]-LY3023414 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Healthy
Interventions
DRUG

[¹⁴C]-LY3023414

LY3023414 in solution containing approximately 100 microCi \[¹⁴C\]-LY3023414

Trial Locations (1)

53704

Covance Clinical Research Inc, Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02575703 - A Study of [¹⁴C]-LY3023414 in Healthy Participants | Biotech Hunter | Biotech Hunter